
Rezilient Health
HaaS company using robotics to allow physicians to perform physical exams over the internet.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $10.0m | Series A | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 116 % | 46 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Rezilient Health, established in 2016, is a tech-enabled healthcare company operating in the hybrid care market. It was co-founded by CEO Dr. Danish Nagda and CTO Dr. Jeff Gamble. Dr. Nagda, a University of Pennsylvania Perelman School of Medicine graduate and ENT surgeon, was motivated by his personal experience as a caregiver for his father. This journey highlighted the inefficiencies of the traditional healthcare system, compelling him to create a more accessible model. Prior to Rezilient, he founded the social learning platform Schoology. Dr. Gamble holds a PhD in neural engineering from Washington University and has a background in biomedical engineering, data science, and machine learning, with a focus on developing novel prosthetics and brain-machine interfaces.
The company's business model targets employers, particularly self-insured businesses, offering a direct primary and specialty care benefit for a predictable monthly subscription fee. This model eliminates out-of-pocket costs for employees and aims to reduce overall healthcare spend for employers by promoting preventative care and reducing costly emergency room visits and hospitalizations. Revenue is generated through these employer subscriptions and value-based care contracts that tie payment to health outcomes rather than the volume of services provided.
Rezilient's core offering is its "CloudClinic," a physical clinic space that bridges the gap between telehealth and in-person visits. Patients visit these neighborhood clinics where a nurse or medic facilitates the appointment, using connected digital diagnostic tools like scopes and probes. A remote physician is live-streamed into the room, viewing the diagnostic data in real-time and conducting the examination. This allows patients to have a physical exam, including labs and imaging, without the doctor being physically present, thereby enabling same-day access to a wide range of primary and specialty care providers. The platform also provides 24/7 virtual care through messaging and video calls. The company has reported a Net Promoter Score (NPS) of 95 and has expanded its services to include over 70 specialties. A significant milestone was closing a $10 million Series A funding round in October 2024 to fuel expansion.
Keywords: hybrid healthcare, CloudClinic, telehealth, direct primary care, value-based care, employer health benefits, corporate healthcare, remote diagnostics, digital health, multispecialty care, virtual care, telerobotics, healthcare subscription, preventative care, health-tech, care coordination, St. Louis, Danish Nagda, Jeff Gamble, concierge healthcare, employee wellness, outpatient services